Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-293.15%
operating margin TTM
-343.24%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.12 |
| peg ratio | -0.07 |
| price to book ratio | 0.42 |
| price to sales ratio | 3.22 |
| enterprise value multiple | -0.85 |
| price fair value | 0.42 |
profitability ratios | |
|---|---|
| gross profit margin | 84.98% |
| operating profit margin | -343.24% |
| pretax profit margin | -293.15% |
| net profit margin | -293.15% |
| return on assets | -29.37% |
| return on equity | -36.23% |
| return on capital employed | -38.38% |
liquidity ratio | |
|---|---|
| current ratio | 7.33 |
| quick ratio | 7.33 |
| cash ratio | 0.59 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 604.81 |
| cash conversion cycle | -604.81 |
| receivables turnover | 0.00 |
| payables turnover | 0.60 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.11 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.12 |
| interest coverage | -39.25 |
| cash flow to debt ratio | -2.61 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.89 |
| cash per share | 2.39 |
| operating cash flow per share | -0.88 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.61 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -226.05 |
Frequently Asked Questions
When was the last time Pyxis Oncology, Inc. (NASDAQ:PYXS) reported earnings?
Pyxis Oncology, Inc. (PYXS) published its most recent earnings results on 12-11-2024.
What is Pyxis Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pyxis Oncology, Inc. (NASDAQ:PYXS)'s trailing twelve months ROE is -36.23%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pyxis Oncology, Inc. (PYXS) currently has a ROA of -29.37%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PYXS's net profit margin stand at?
PYXS reported a profit margin of -293.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PYXS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.33 in the most recent quarter. The quick ratio stood at 7.33, with a Debt/Eq ratio of 0.13.